Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.38 |
| ▸ | GPR3 | P46089 | 1/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4498650 | 0.79 | KDM4E (0.44) | KDM4EGPR3ALDH1A1NPC1CYP11B2 | |
| SCHEMBL4501312 | 0.69 | MAPK8 (0.35) | KDM4EALDH1A1RAB9ALMNAADORA2A | |
| SCHEMBL4494026 | 0.69 | KDM4E (0.47) | KDM4EGPR3ALDH1A1SMN1; SMN2NPC1 | |
| SCHEMBL4486727 | 0.68 | ALDH1A1 (0.40) | KDM4EGPR3ALDH1A1HPGDL3MBTL1 | |
| SCHEMBL2683475 | 0.68 | KDM4E (0.45) | KDM4EGPR3ALDH1A1SMN1; SMN2NPC1 | |
| SCHEMBL16552325 | 0.66 | PDE2A (0.38) | KDM4EALDH1A1NPC1RAB9AADORA3 | |
| SCHEMBL1368540 | 0.66 | PARP1 (0.41) | KDM4EALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL12145153 | 0.66 | MAPT (0.43) | KDM4EALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL15603262 | 0.66 | PARP1 (0.41) | KDM4EALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL29881244 | 0.65 | NPSR1 (0.47) | KDM4EALDH1A1NPC1RAB9AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4305098-A1 | USE OF AT LEAST ONE SULFUR-CONTAINING AMINO ACID FOR STABILIZING RECYCLED THERMOPLASTICS, STABILIZED RECYCLED THERMOPLASTIC, STABILIZER COMPOSITION, MASTERBATCH, AND MOLDING COMPOUND OR MOLDED PART | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2024-01-17 | — | — | EP | claimed |
| CN-122029144-A | Apparatus and condensation method | 三菱化学英国有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20240043745-A1 | USE OF EUGENOL DERIVATIVES AS STABILIZERS, ORGANIC MATERIAL AND EUGENOL DERIVATIVES | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2024-02-08 | — | — | US | disclosed |
| EP-4305098-A1 | USE OF AT LEAST ONE SULFUR-CONTAINING AMINO ACID FOR STABILIZING RECYCLED THERMOPLASTICS, STABILIZED RECYCLED THERMOPLASTIC, STABILIZER COMPOSITION, MASTERBATCH, AND MOLDING COMPOUND OR MOLDED PART | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2024-01-17 | — | — | EP | disclosed |
| EP-4237484-A1 | USE OF EUGENOL DERIVATIVES AS STABILIZERS, ORGANIC MATERIAL AND EUGENOL DERIVATIVES | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-09-06 | — | — | EP | disclosed |
| EP-4127045-A1 | USE OF HYDROXYCINNAMIC ACID SALTS FOR STABILISING ORGANIC MATERIALS, STABILISED ORGANIC MATERIAL, METHOD FOR STABILISING ORGANIC MATERIALS, SPECIFIC STABILISERS AND STABILISER COMPOSITIONS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-02-08 | — | — | EP | disclosed |
| EP-2828353-B1 | ISOINDOLO[2,1-A]QUINAZOLINE DERIVATIVES FOR STABILIZATION OF ORGANIC MATERIALS | BASF SE (DE) | 2016-05-18 | — | — | EP | disclosed |
| US-9321902-B2 | Isoindolo[2, 1-A]quinazoline derivatives for stabilization of organic materials | BASF SE (DE) | 2016-04-26 | — | — | US | disclosed |
| US-9321902-B2 | Isoindolo[2, 1-A]quinazoline derivatives for stabilization of organic materials | BASF SE (DE) | 2016-04-26 | — | — | US | disclosed |
| US-20150087755-A1 | ISOINDOLO[2, 1-A]QUINAZOLINE DERIVATIVES FOR STABILIZATION OF ORGANIC MATERIALS | BASF SE (DE) | 2015-03-26 | — | — | US | disclosed |
| US-20040053826-A1 | Uses of polypeptides | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-03-18 | — | — | US | disclosed |
| US-20030207863-A1 | Preventives and remedies for central nervous system diseases | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2003-11-06 | — | — | US | disclosed |
| EP-1331010-A1 | PREVENTIVES AND REMEDIES FOR CENTRAL NERVOUS SYSTEM DISEASES | Takeda Chemical Industries, Ltd. (JP) | 2003-07-30 | — | — | EP | disclosed |
| EP-1310490-A1 | GPR14 ANTAGONIST | Takeda Chemical Industries, Ltd. (JP) | 2003-05-14 | — | — | EP | disclosed |
| EP-1308513-A1 | USE OF POLYPEPTIDE | Takeda Chemical Industries, Ltd. (JP) | 2003-05-07 | — | — | EP | disclosed |
| US-6534496-B1 | Prophylactic and/or therapeutic drug for obesity and obesity associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the a lipolytic agent, or a prophylactic and/or | TAKEDA CHEMICAL INDUSTRIES, INC. (JP) | 2003-03-18 | — | — | US | disclosed |
| US-20020177593-A1 | Agents and crystals for improving excretory potency of urinary bladder | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2002-11-28 | — | — | US | disclosed |
| EP-1118322-A1 | DRUGS FOR IMPROVING VESICAL EXCRETORY STRENGTH | Takeda Chemical Industries, Ltd. (JP) | 2001-07-25 | — | — | EP | disclosed |
| US-5620973-A | CHOLINESTERASE INHIBITOR; ALZHEIMER*S DISEASE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-04-15 | — | — | US | disclosed |
| EP-0655451-A1 | Tetracyclic condensed heterocyclic compounds for the treatment of senile dementia | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-05-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087755-A1 | ISOINDOLO[2, 1-A]QUINAZOLINE DERIVATIVES FOR STABILIZATION OF ORGANIC MATERIALS | SQLE, MYC, CYP4Z1 | KDM4E 4802/4885GPR3 1136/4885PTGER4 1385/4885 |
| US-20020177593-A1 | Agents and crystals for improving excretory potency of urinary bladder | ACHE, BPHL, BCHE | KDM4E 306/4885GPR3 1696/4885PTGER4 2690/4885 |
| US-20040053826-A1 | Uses of polypeptides | NPSR1, SCTR, GRPR | KDM4E 4438/4885GPR3 130/4885PTGER4 3969/4885 |
| US-20240043745-A1 | USE OF EUGENOL DERIVATIVES AS STABILIZERS, ORGANIC MATERIAL AND EUGENOL DERIVATIVES | GSR, GAPDH, GPX4 | KDM4E 760/4885GPR3 3345/4885PTGER4 1499/4885 |
| US-20030207863-A1 | Preventives and remedies for central nervous system diseases | UTS2R, PRSS12, CTSA | KDM4E 4866/4885GPR3 501/4885PTGER4 2883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.